Current understanding of the mechanism of action of the antiepileptic drug lacosamide

@article{Rogawski2015CurrentUO,
  title={Current understanding of the mechanism of action of the antiepileptic drug lacosamide},
  author={Michael A. Rogawski and Azita Tofighy and H. Steve White and Alain Matagne and Christian Wolff},
  journal={Epilepsy Research},
  year={2015},
  volume={110},
  pages={189-205}
}
The antiepileptic drug lacosamide [(R)-2-acetamido-N-benzyl-3-methoxypropanamide], a chiral functionalized amino acid, was originally identified by virtue of activity in the mouse and rat maximal electroshock (MES) test. Attention was drawn to lacosamide because of its high oral potency and stereoselectivity. Lacosamide is also active in the 6 Hz seizure model but inactive against clonic seizures in rodents induced by subcutaneous pentylenetetrazol, bicuculline and picrotoxin. It is also… 
Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice
TLDR
The combinations of ivabradine with lacosamide, pregabalin and topiramate seem to be pharmacodynamic and neutral from a preclinical viewpoint, and the anticonvulsant potency of four novel antiepileptic drugs appears to be unchanged.
The 4-Aminopyridine Model of Acute Seizures in vitro Elucidates Efficacy of New Antiepileptic Drugs
TLDR
There is some evidence that acute seizure models in vitro are in principle capable to detect antiepileptic effects across different mechanisms of action with efficacy similar to acute models in vivo.
Preliminary Evaluation of the Antiepileptic Activity of Lacosamide in Libyan Epileptic Center.
TLDR
Adjunctive lacosamide was safe, efficacious, well tolerated and dramatically reduced seizures in patients with intractable epilepsy who had failed by other AEDs, however, epilepsy still can be controlled but not totally cured.
Isobolographic additivity among lacosamide, lamotrigine and phenobarbital in a mouse tonic-clonic seizure model.
TLDR
The combination of LCM with LTG and PB produced additive interaction in the mouse tonicclonic seizure model, despite various molecular mechanisms of action of the tested AEDs.
Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy
TLDR
The present preclinical results proved that novel hybrid molecules demonstrate very promising anticonvulsant and analgesic activity.
Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications.
TLDR
The pharmacology, pharmacokinetics, and clinical data of lacosamide were reviewed, giving special emphasis to the latest molecular investigations underlying its mechanism of action and therapeutic applications in pathologies other than epilepsy.
Mechanisms of action of currently used antiseizure drugs
TLDR
Attempts are being made to engineer specific small molecule, antisense and gene therapies that functionally reverse or structurally correct pathogenic defects in epilepsy syndromes, but targeted therapies will remain elusive for the vast majority of epilepsies until their causes are identified.
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
TLDR
The in vivo anticonvulsant effects observed in this study for ligands 1–6 showed stereoselectivity in different convulsion models in male adult rats, comparable with those observed for PHT, and reversed when rats were pretreated with the selective H3R agonist R-(α)-methyl-histamine.
Role of Lacosamide in Preventing Pentylenetetrazole Kindling-Induced Alterations in the Expression of the Gamma-2 Subunit of the GABAA Receptor in Rats.
TLDR
LCM could exhibit modulatory effects on the GABAergic system of the hippocampus that may be independent of the anticonvulsant action.
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet.
TLDR
The ketogenic diet leads to increases in circulating ketones, which may contribute to the efficacy in treating pharmacoresistant seizures, and is one treatment option for drug-resistant patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 154 REFERENCES
Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy
TLDR
The results suggest that lacosamide may have the potential to be clinically useful for at least the treatment of generalized tonic-clonic and partial-onset epilepsies, and support ongoing clinical trials in these indications.
A calcium antagonistic effect of the new antiepileptic drug lamotrigine
TLDR
The interaction of lamotrigine with carbamazepine and the organic calcium channel blocker verapamil was analyzed in the low Mg(2+)-induced model epilepsy which has been shown to be suppressed specifically by organic calcium antagonists.
Effects of the Novel Antiepileptic Drug Lacosamide on the Development of Amygdala Kindling in Rats
TLDR
The kindling model is used to evaluate whether the novel AED lacosamide affects kindling‐induced epileptogenesis, and this drug does not seem to act by any of the mechanisms of currently available AEDs, but the exact molecular mechanisms of action have not yet been clarified.
Lacosamide for the treatment of partial-onset seizures
  • V. Biton
  • Medicine
    Expert review of neurotherapeutics
  • 2012
TLDR
Safety and efficacy data from three double-blind, placebo-controlled trials, as well as pooled and post hoc analyses of these three trials, have been published, and demonstrate the safety and rapid-onset efficacy of LCM in adults with treatment-refractory partial-ONSet seizures.
Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.
TLDR
The findings support the further use of these agents to delineate the (R)-1-mediated Na(+) channel slow inactivation process and support a strategy to identify lacosamide binding partners by attaching affinity bait and chemical reporter groups to (R-1) to aid receptor detection and isolation.
Lacosamide: a review of preclinical properties.
TLDR
It was found that LCM selectively enhances slow inactivation of voltage-gated sodium channels without affecting fast inactivation, and collapsin-response mediator protein 2 (CRMP-2 alias DRP-2) was identified as a binding partner.
Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound.
TLDR
The results suggest that PNU-151774E exerts its anticonvulsant activity, at least in part, through inhibition of sodium and calcium channels, stabilizing neuronal membrane excitability and inhibiting transmitter release.
The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus
TLDR
The results presented here suggest that lacosamide deserves investigation for the clinical treatment of SE, and potential for disease modification in this rat model of self-sustaining SE will require further studies.
Seeking a mechanism of action for the novel anticonvulsant lacosamide
TLDR
Evidently LCM perturbs excitability in primary cortical cultures but does not appear to do so via a high-affinity interaction with an acknowledged recognition site on a target for existing antiepileptic drugs.
[Lacosamide in the treatment of epilepsy].
TLDR
Evidence is provided that lacosamide is a prospective preparation for complex treatment of drug-resistant epilepsy in the view of its safety and tolerability and the availability of the infusion form is advantageous making it possible to continue treatment in cases when the peroral intake of AED is temporary impossible.
...
1
2
3
4
5
...